Bioprocessing equipment and consumables for monoclonal antibody manufacturing
Repligen manufactures chromatography columns, filtration systems, and process consumables for biologic drug production, with 40+ years in the space. Current priorities reveal operational scaling under pressure: lean implementation, M&A integration, automation, and new product launches are running in parallel, while pain points cluster around supplier qualification, waste reduction, and documentation velocity—typical friction points when a mid-cap biotech grows manufacturing footprint globally.
Notable leadership hires: Finance Director, Operations Lead, Manufacturing Director
Repligen is a publicly traded bioprocessing company focused on high-value consumables and equipment for monoclonal antibody production. The product portfolio centers on chromatography (Protein A columns, pre-packed formats), tangential and alternating tangential flow filtration, and related bioprocess tools. Manufacturing and R&D are distributed across facilities worldwide; commercial teams operate directly in the U.S., Europe, and Asia, with partners in select other regions. The company serves biopharma customers scaling from clinical through commercial manufacturing.
Headquarters in Waltham, MA with manufacturing facilities distributed globally. Active hiring in Germany, U.S., Ireland, Netherlands, India, U.K., Estonia, Switzerland, and Sweden signals multi-continent production and supply-chain presence.
CAD/CAM tools (SolidWorks, Fusion 360, Mastercam), enterprise resource planning (SAP), HR/finance (Workday), CRM (Salesforce), service management (ServiceNow), data and analytics (Snowflake, dbt, SQL), and Microsoft Office suite. Currently replacing Tableau with Power BI for reporting.
Other companies in the same industry, closest in size